{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:05:27Z","timestamp":1789779927158,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T00:00:00Z","timestamp":1422230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T00:00:00Z","timestamp":1422230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep08022","type":"journal-article","created":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T10:05:02Z","timestamp":1422266702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["AhR expression and polymorphisms are associated with risk of coronary arterial disease in Chinese population"],"prefix":"10.1038","volume":"5","author":[{"given":"Shian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,26]]},"reference":[{"key":"BFsrep08022_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2008.07.156","volume":"375","author":"CF Vogel","year":"2008","unstructured":"Vogel, C. F., Goth, S. R., Dong, B., Pessah, I. N. & Matsumura, F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun 375, 331\u2013335 (2008).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep08022_CR2","doi-asserted-by":"publisher","first-page":"e86549","DOI":"10.1371\/journal.pone.0086549","volume":"9","author":"Y Wu","year":"2014","unstructured":"Wu, Y. et al. ITE and TCDD differentially regulate the vascular remodeling of rat placenta via the activation of AhR. PloS One 9, e86549 (2014).","journal-title":"PloS One"},{"key":"BFsrep08022_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/0975-3583.83033","volume":"2","author":"N Zhang","year":"2011","unstructured":"Zhang, N. The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology. J Cardiovasc Dis Res 2, 91\u201395 (2011).","journal-title":"J Cardiovasc Dis Res"},{"key":"BFsrep08022_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/intimm\/dxt011","volume":"25","author":"NT Nguyen","year":"2013","unstructured":"Nguyen, N. T., Hanieh, H., Nakahama, T. & Kishimoto, T. The roles of aryl hydrocarbon receptor in immune responses. Int Immunol 25, 335\u2013343 (2013).","journal-title":"Int Immunol"},{"key":"BFsrep08022_CR5","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/eji.201343920","volume":"44","author":"L Prigent","year":"2014","unstructured":"Prigent, L. et al. The aryl hydrocarbon receptor is functionally upregulated early in the course of human T-cell activation. Eur J Immunol 44, 1330\u20131340 (2014).","journal-title":"Eur J Immunol"},{"key":"BFsrep08022_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/toxsci\/kfs002","volume":"126","author":"JS Kerley-Hamilton","year":"2012","unstructured":"Kerley-Hamilton, J. S. et al. Inherent and benzo[a]pyrene-induced differential aryl hydrocarbon receptor signaling greatly affects life span, atherosclerosis, cardiac gene expression and body and heart growth in mice. Toxicol Sci 126, 391\u2013404 (2012).","journal-title":"Toxicol Sci"},{"key":"BFsrep08022_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1161\/HYPERTENSIONAHA.107.100586","volume":"51","author":"AK Lund","year":"2008","unstructured":"Lund, A. K. et al. Loss of the aryl hydrocarbon receptor induces hypoxemia, endothelin-1 and systemic hypertension at modest altitude. Hypertension 51, 803\u2013809 (2008).","journal-title":"Hypertension"},{"key":"BFsrep08022_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.taap.2003.08.008","volume":"193","author":"AK Lund","year":"2003","unstructured":"Lund, A. K., Goens, M. B., Kanagy, N. L. & Walker, M. K. Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1 and mean arterial blood pressure. Toxicol Appl Pharmacol 193, 177\u2013187 (2003).","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFsrep08022_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1385\/CT:2:4:263","volume":"2","author":"EA Thackaberry","year":"2002","unstructured":"Thackaberry, E. A., Gabaldon, D. M., Walker, M. K. & Smith, S. M. Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxiainducible factor-1alpha in the absence of cardiac hypoxia. Cardiovasc Toxicol 2, 263\u2013274 (2002).","journal-title":"Cardiovasc Toxicol"},{"key":"BFsrep08022_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1385\/CT:3:2:153","volume":"3","author":"A Vasquez","year":"2003","unstructured":"Vasquez, A. et al. A role for the aryl hydrocarbon receptor in cardiac physiology and function as demonstrated by AhR knockout mice. Cardiovasc Toxicol 3, 153\u2013163 (2003).","journal-title":"Cardiovasc Toxicol"},{"key":"BFsrep08022_CR11","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/ATVBAHA.110.220202","volume":"31","author":"D Wu","year":"2011","unstructured":"Wu, D. et al. Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E\u2212\/\u2212 mice. Arterioscler Thromb Vasc Biol 31, 1260\u20131267 (2011).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep08022_CR12","doi-asserted-by":"publisher","first-page":"e66924","DOI":"10.1371\/journal.pone.0066924","volume":"8","author":"YW Yin","year":"2013","unstructured":"Yin, Y. W. et al. Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Chinese population: evidence from a meta-analysis of 40 studies. PloS One 8, e66924 (2013).","journal-title":"PloS One"},{"key":"BFsrep08022_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/FPC.0b013e32833605f8","volume":"20","author":"CJ Rowlands","year":"2010","unstructured":"Rowlands, C. J., Staskal, D. F., Gollapudi, B. & Budinsky, R. The human AHR: identification of single nucleotide polymorphisms from six ethnic populations. Pharmacogenet Genomics 20, 283\u2013290 (2010).","journal-title":"Pharmacogenet Genomics"},{"key":"BFsrep08022_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1615\/CritRevEukarGeneExpr.v18.i3.20","volume":"18","author":"TV Beischlag","year":"2008","unstructured":"Beischlag, T. V., Luis, M. J., Hollingshead, B. D. & Perdew, G. H. The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr 18, 207\u2013250 (2008).","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"BFsrep08022_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.taap.2008.07.009","volume":"232","author":"M Frericks","year":"2008","unstructured":"Frericks, M., Burgoon, L. D., Zacharewski, T. R. & Esser, C. Promoter analysis of TCDD-inducible genes in a thymic epithelial cell line indicates the potential for cell-specific transcription factor crosstalk in the AhR response. Toxicol Appl Pharmacol 232, 268\u2013279 (2008).","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFsrep08022_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/FPC.0b013e328316d8d8","volume":"19","author":"D Chen","year":"2009","unstructured":"Chen, D. et al. Association of human aryl hydrocarbon receptor gene polymorphisms with risk of lung cancer among cigarette smokers in a Chinese population. Pharmacogenet Genomics 19, 25\u201334 (2009).","journal-title":"Pharmacogenet Genomics"},{"key":"BFsrep08022_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ijc.24434","volume":"125","author":"S Sangrajrang","year":"2009","unstructured":"Sangrajrang, S. et al. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer 125, 837\u2013843 (2009).","journal-title":"Int J Cancer"},{"key":"BFsrep08022_CR18","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1365-2133.2011.10798.x","volume":"166","author":"XW Wang","year":"2012","unstructured":"Wang, X. W. et al. The association of functional polymorphisms in the aryl hydrocarbon receptor (AHR) gene with the risk of vitiligo in Han Chinese populations. Br J Dermatol 166, 1081\u20131087 (2012).","journal-title":"Br J Dermatol"},{"key":"BFsrep08022_CR19","doi-asserted-by":"publisher","first-page":"202.e9","DOI":"10.1016\/j.ajog.2012.05.019","volume":"207","author":"A Ziv-Gal","year":"2012","unstructured":"Ziv-Gal, A., Gallicchio, L., Miller, S. R., Zacur, H. A. & Flaws, J. A. Genetic polymorphisms in the aryl hydrocarbon receptor signaling pathway as potential risk factors of menopausal hot flashes. Am J Obstet Gynecol 207, 202.e9\u2013202.e18 (2012).","journal-title":"Am J Obstet Gynecol"},{"key":"BFsrep08022_CR20","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs289","volume":"33","author":"PG Steg","year":"2012","unstructured":"Steg, P. G. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33, 2569\u20132619 (2012).","journal-title":"Eur Heart J"},{"key":"BFsrep08022_CR21","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","volume":"33","author":"K Thygesen","year":"2012","unstructured":"Thygesen, K. et al. Third universal definition of myocardial infarction. Eur Heart J 33, 2551\u20132567 (2012).","journal-title":"Eur Heart J"},{"key":"BFsrep08022_CR22","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1289\/ehp.11579","volume":"116","author":"O Humblet","year":"2008","unstructured":"Humblet, O., Birnbaum, L., Rimm, E., Mittleman, M. A. & Hauser, R. Dioxins and cardiovascular disease mortality. Environ Health Perspect 116, 1443\u20131448 (2008).","journal-title":"Environ Health Perspect"},{"key":"BFsrep08022_CR23","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1253\/circj.CJ-14-0343","volume":"78","author":"L Xiao","year":"2014","unstructured":"Xiao, L., Zhang, Z. & Luo, X. Roles of xenobiotic receptors in vascular pathophysiology. Circ J 78, 1520\u20131530 (2014).","journal-title":"Circ J"},{"key":"BFsrep08022_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4330\/wjc.v6.i7.663","volume":"6","author":"G Gitsioudis","year":"2014","unstructured":"Gitsioudis, G., Katus, H. A. & Korosoglou, G. Assessment of coronary artery disease using coronary computed tomography angiography and biochemical markers. World J Cardiol 6, 663\u2013670 (2014).","journal-title":"World J Cardiol"},{"key":"BFsrep08022_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/CIRCULATIONAHA.105.570762","volume":"113","author":"B Zethelius","year":"2006","unstructured":"Zethelius, B., Johnston, N. & Venge, P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 113, 1071\u20131078 (2006).","journal-title":"Circulation"},{"key":"BFsrep08022_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0009-2797(02)00071-6","volume":"141","author":"PA Harper","year":"2002","unstructured":"Harper, P. A., Wong, J. Y., Lam, M. S. & Okey, A. B. Polymorphisms in the human AH receptor. Chem Biol Interact 141, 161\u2013187 (2002).","journal-title":"Chem Biol Interact"},{"key":"BFsrep08022_CR27","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1006\/bbrc.2001.5861","volume":"288","author":"JM Wong","year":"2001","unstructured":"Wong, J. M., Okey, A. B. & Harper, P. A. Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem Biophys Res Commun 288, 990\u2013996 (2001).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep08022_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00008571-200102000-00010","volume":"11","author":"JM Wong","year":"2001","unstructured":"Wong, J. M. et al. Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro. Pharmacogenetics 11, 85\u201394 (2001).","journal-title":"Pharmacogenetics"},{"key":"BFsrep08022_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00008571-199506000-00003","volume":"5","author":"K Kawajiri","year":"1995","unstructured":"Kawajiri, K. et al. Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 5, 151\u2013158 (1995).","journal-title":"Pharmacogenetics"},{"key":"BFsrep08022_CR30","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1158\/1055-9965.EPI-05-0076","volume":"14","author":"L Le Marchand","year":"2005","unstructured":"Le Marchand, L., Donlon, T., Kolonel, L. N., Henderson, B. E. & Wilkens, L. R. Estrogen metabolism related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14, 1998\u20132003 (2005).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFsrep08022_CR31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/MCA.0000000000000035","volume":"24","author":"K Zhao","year":"2013","unstructured":"Zhao, K. et al. Autophagy of monocytes attenuates the vulnerability of coronary atherosclerotic plaques. Coron Artery Dis 24, 651\u2013656 (2013).","journal-title":"Coron Artery Dis"},{"key":"BFsrep08022_CR32","first-page":"351","volume":"98","author":"P Gavorn\u00edk","year":"1997","unstructured":"Gavorn\u00edk, P. Unstable atherosclerotic plaque and acute coronary syndromes. Bratisl Lek Listy 98, 351\u2013359 (1997).","journal-title":"Bratisl Lek Listy"},{"key":"BFsrep08022_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0008-6363(98)00322-8","volume":"41","author":"DE Gutstein","year":"1999","unstructured":"Gutstein, D. E. & Fuster, V. Pathophysiology and clinical significance of atherosclerotic plaque rupture. Cardiovasc Res 41, 323\u2013333 (1999).","journal-title":"Cardiovasc Res"},{"key":"BFsrep08022_CR34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/oxfordjournals.aje.a117575","volume":"142","author":"D Flesch-Janys","year":"1995","unstructured":"Flesch-Janys, D. et al. Exposure to polychlorinated dioxins and furans (PCDD\/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. Am J Epidemiol 142, 1165\u20131175 (1995).","journal-title":"Am J Epidemiol"},{"key":"BFsrep08022_CR35","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1289\/ehp.10554","volume":"116","author":"V Arsenescu","year":"2008","unstructured":"Arsenescu, V., Arsenescu, R. I., King, V., Swanson, H. & Cassis, L. A. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect 116, 761\u2013768 (2008).","journal-title":"Environ Health Perspect"},{"key":"BFsrep08022_CR36","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1007\/s00420-002-0350-4","volume":"75","author":"D Pelclova","year":"2002","unstructured":"Pelclova, D. et al. Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8- tetrachlordibenzop-dioxin. Int Arch Occup Environ Health 75, S60\u2013S66 (2002).","journal-title":"Int Arch Occup Environ Health"},{"key":"BFsrep08022_CR37","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/0006-291X(84)91337-8","volume":"118","author":"DW Bombick","year":"1984","unstructured":"Bombick, D. W., Matsumura, F. & Madhukar, B. V. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes reduction in the low density lipoprotein (LDL) receptor activities in the hepatic plasma membrane of the guinea pig and rat. Biochem Biophys Res Commun 118, 548\u2013554 (1984).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep08022_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1385\/CT:4:4:363","volume":"4","author":"CF Vogel","year":"2004","unstructured":"Vogel, C. F., Sciullo, E. & Matsumura, F. Activation of inflammatory mediators and potential role of ah-receptor ligands in foam cell formation. Cardiovasc Toxicol 4, 363\u2013373 (2004).","journal-title":"Cardiovasc Toxicol"},{"key":"BFsrep08022_CR39","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1289\/ehp.8094","volume":"113","author":"CF Vogel","year":"2005","unstructured":"Vogel, C. F. et al. Induction of proinflammatory cytokines and C-reactive protein in human macrophage cell line U937 exposed to air pollution particulates. Environ Health Perspect 113, 1536\u20131541 (2005).","journal-title":"Environ Health Perspect"},{"key":"BFsrep08022_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/cvr\/cvp007","volume":"82","author":"N Podechard","year":"2009","unstructured":"Podechard, N., Le Ferrec, E., Rebillard, A., Fardel, O. & Lecureur, V. NPC1 repression contributes to lipid accumulation in human macrophages exposed to environmental aryl hydrocarbons. Cardiovasc Res 82, 361\u2013370 (2009).","journal-title":"Cardiovasc Res"},{"key":"BFsrep08022_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0742-8413(98)10028-2","volume":"121","author":"ME Hahn","year":"1998","unstructured":"Hahn, M. E. The aryl hydrocarbon receptor: a comparative perspective. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 121, 23\u201353 (1998).","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"key":"BFsrep08022_CR42","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.1074\/jbc.M110779200","volume":"277","author":"SI Karchner","year":"2002","unstructured":"Karchner, S. I., Franks, D. G., Powell, W. H. & Hahn, M. E. Regulatory interactions among three members of the vertebrate aryl hydrocarbon receptor family: AHR repressor, AHR1 and AHR2. J Biol Chem 277, 6949\u20136959 (2002).","journal-title":"J Biol Chem"},{"key":"BFsrep08022_CR43","doi-asserted-by":"publisher","first-page":"L391","DOI":"10.1152\/ajplung.00062.2005","volume":"289","author":"CA Martey","year":"2005","unstructured":"Martey, C. A., Baglole, C. J., Gasiewicz, T. A., Sime, P. J. & Phipps, R. P. The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 289, L391\u2013L399 (2005).","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep08022","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep08022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep08022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:06:11Z","timestamp":1672952771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep08022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,26]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,7,15]]}},"alternative-id":["BFsrep08022"],"URL":"https:\/\/doi.org\/10.1038\/srep08022","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,26]]},"assertion":[{"value":"12 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8022"}}